Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine
Sanofi Pasteur and Translate Bio this week announced plans to collaborate to develop a novel messenger RNA (mRNA) vaccine for COVID-19. ...
Tag: Drug Development
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them?
SARS-CoV-2 – the coronavirus that causes the disease COVID-19 – is completely new and attacks cells in a novel way. ...
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of ...
Hotel Influenza: Research Heats Up on Universal Flu Vaccines
A universal flu vaccine has eluded scientists for decades. Unlike other viruses, influenza has a rapid-fire mutation rate and thousands ...
Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. Pfizer Inc. and BioNTech SE today announced ...
Janssen Scientists Collaborate with BIDMC Virology Lab to Accelerate COVID-19 Vaccine Development
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical ...
BAA for COVID-19 Diagnostics, Vaccines and Therapeutics
As part of the government-wide effort to mitigate the spread of COVID-19 in U.S. communities, the U.S. Department of Health ...
Viral Vaccines to Combat SARS-CoV-2 Pneumonia
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly. Development of SARS-CoV-2-based vaccines is ...
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership
Daniel Menichella, CEO of biopharmaceutical company CureVac, was today invited to the White House to discuss strategies and opportunities for ...
New Coronavirus Protein Reveals Drug Target
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). ...
Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine
Senator Edward J. Markey (D-Mass.) today introduced legislation to conduct or support comprehensive research for the creation of a universal ...
Health Security Today – 27 Feb 2020
FEATURED POLICY + PREPAREDNESS Schumer Proposes $8.5 Billion in Emergency Coronavirus Funding Senate Democratic Leader Chuck Schumer (D-NY) today released ...
University of Queensland COVID-19 Vaccine Goes Into Test Production
A University of Queensland team has met a key milestone in their fast-tracked research to develop a vaccine for the ...
Tulane National Primate Research Center Launches Coronavirus Research Program
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing ...
HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine
Racing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department of Health and Human Services’ Office of ...
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research ...
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning
Soligenix, Inc. announced on Feb. 13 that its RiVax® (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication ...
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses
The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially ...
Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient
Virologist Matthew Frieman at the University of Maryland School of Medicine is just one of the scientists cleared to receive ...
The Native Antigen Company Introduces Novel Coronavirus Antigens
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development The ...
